Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Cash from Investing Activities (2016 - 2018)

Armata Pharmaceuticals' Cash from Investing Activities history spans 6 years, with the latest figure at -$535000.0 for Q4 2018.

  • For Q4 2018, Cash from Investing Activities fell 2872.22% year-over-year to -$535000.0; the TTM value through Dec 2018 reached -$597000.0, down 929.31%, while the annual FY2024 figure was -$1.9 million, 76.9% up from the prior year.
  • Cash from Investing Activities for Q4 2018 was -$535000.0 at Armata Pharmaceuticals, down from -$11000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at -$2000.0 in Q2 2017 and bottomed at -$831000.0 in Q2 2014.
  • The 5-year median for Cash from Investing Activities is -$33000.0 (2017), against an average of -$141333.3.
  • The largest annual shift saw Cash from Investing Activities surged 98.4% in 2017 before it plummeted 2872.22% in 2018.
  • A 5-year view of Cash from Investing Activities shows it stood at -$5000.0 in 2014, then plummeted by 600.0% to -$35000.0 in 2015, then skyrocketed by 62.86% to -$13000.0 in 2016, then crashed by 38.46% to -$18000.0 in 2017, then tumbled by 2872.22% to -$535000.0 in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Cash from Investing Activities are -$535000.0 (Q4 2018), -$11000.0 (Q3 2018), and -$18000.0 (Q4 2017).